Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

0.445
Delayed Data
As of 10:04am ET
 +0.02 / +4.71%
Today’s Change
0.26
Today|||52-Week Range
1.98
-66.29%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close0.43
Today’s open0.42
Day’s range0.42 - 0.45
Volume50,759
Average volume (3 months)985,463
Market cap$16.8M
Dividend yield--
Data as of 10:04am ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+41.67%
Earnings growth (this year)-52.86%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.80

Competitors

 Today’s
change
Today’s
% change
SBOTStellar Biotechnolog...+0.01+0.89%
EVARFLombard Medical Inc0.000.00%
ARGSArgos Therapeutics I...-0.01-2.61%
HEBHemispherx Biopharma...+0.00+0.32%
Data as of 10:05am ET, 11/22/2017

Financials

Last reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$17.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Larry M. Dillaha
CFO, Secretary &
Principal Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts